TriasLab is projected to rise to $0.5977 by 2027, a +51% move from its current price of $0.3965. TRIAS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.3664 | $0.3975 | $0.4312 | +0.25% |
| Jul 14 | $0.3552 | $0.3985 | $0.4471 | +0.50% |
| Jul 15 | $0.3469 | $0.3995 | $0.4599 | +0.74% |
| Jul 16 | $0.3403 | $0.4004 | $0.4712 | +0.99% |
| Jul 17 | $0.3346 | $0.4014 | $0.4815 | +1.24% |
| Jul 18 | $0.3297 | $0.4024 | $0.4912 | +1.49% |
| Jul 19 | $0.3253 | $0.4034 | $0.5003 | +1.74% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3253 | $0.4034 | $0.5003 | +1.74% |
| Week 2 | $0.3027 | $0.4105 | $0.5566 | +3.52% |
| Week 3 | $0.2876 | $0.4176 | $0.6064 | +5.33% |
| Week 4 | $0.2762 | $0.4249 | $0.6536 | +7.16% |
| Week 5 | $0.2671 | $0.4323 | $0.6997 | +9.03% |
| Week 6 | $0.2596 | $0.4399 | $0.7454 | +10.94% |
| Week 7 | $0.2532 | $0.4475 | $0.7911 | +12.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TriasLab (TRIAS) is described as a platform focused on trustworthy, intelligent autonomous systems. It is presented as a native-application-compatible smart contract execution platform with a development framework and collaborating ecosystem. TriasLab aims to define a new-generation all-platform-supported public chain system focused on trustworthy and reliable intelligent autonomous systems that aim to make people trust in machines.
The asset sits within multiple categories, including Artificial Intelligence, Smart Contract Platform, BN B Chain Ecosystem, Layer 1, Ethereum Ecosystem, and AI Agents. This positioning reflects its dual emphasis on AI-enabled agents and decentralized applications built on public-chain infrastructure.
As a project, TRIAS seeks to harmonize intelligent automation with public blockchain capabilities, enabling machines and software to operate in trustworthy, automated ways within a broad ecosystem of platform-wide compatibility.
TriasLab is currently priced at $0.3965 and has a market capitalization around $3.97M, with a rank of 1707 globally. The near-term outlook shows modest current pricing around the present level, while the multi-year forecast envisions gradual upside across several years.
In 2026 the forecast lists min $0.2089, avg $0.3965, max $0.8183, indicating a broadly flat to modestly positive trajectory. The 2027 projection improves to avg $0.5977 with a 50.7% ROI and a bullish sentiment, suggesting continued upside potential. Longer horizons show stronger upside, with 2030 averaging $0.5889 and a max of $1.02 (48.5% ROI), 2031 averaging $0.8773 (121.3% ROI), and 2032 averaging $0.6819 (72% ROI).
By 2034 the forecast shows avg $0.6804 and 71.6% ROI, advancing to 2035 avg $1.06 with 166.9% ROI. The 2040 outlook is $1.55 avg and 291.7% ROI, culminating in 2050 at $1.82 avg and 357.8% ROI along with a max price of $4.17.
A major floor 41.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.9% below — buyers have tended to step in here.
The nearest ceiling, 17.8% above — a clean break opens room to run.
A major ceiling 73.1% above — clearing it would confirm fresh momentum.
Key TRIAS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TRIAS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3749 | Buy | $0.3788 | Buy |
| MA 10 | $0.4004 | Sell | $0.3866 | Buy |
| MA 20 | $0.3917 | Buy | $0.386 | Buy |
| MA 50 | $0.3699 | Buy | $0.3946 | Buy |
| MA 100 | $0.4465 | Sell | $0.432 | Sell |
| MA 200 | $0.4981 | Sell | $0.5195 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.83 | Neutral |
| Stoch RSI (14) | 44.87 | Neutral |
| CCI (20) | 10.82 | Neutral |
| Williams %R (14) | -51.97 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -8.82 | Sell |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 48.03 | Neutral |
| TRIX (15) | 0.37 | Buy |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 42.53 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 0.35 | Buy |
| ADX (14) | 12.17 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 50, and the short-term moving averages sit around the current level with SMA50 at $0.3713 and SMA200 at $0.4984. Near-term support stands at $0.3137, with resistance at $0.4671.
The 30-day price range runs from a low of $0.2539 to a high of $0.6192, indicating a contained but more volatile session space. Annualized volatility sits at 200%, signaling elevated swings in the price path.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.2089 | $0.3965 | $0.8183 | 0% | Neutral | |
| $0.4325 | $0.5977 | $0.8932 | +51% | Bullish | |
| $0.2697 | $0.396 | $0.6303 | 0% | Neutral | |
| $0.2279 | $0.3525 | $0.589 | -11% | Neutral | |
| $0.3632 | $0.5889 | $1.02 | +49% | Bullish | |
| $0.5176 | $0.8773 | $1.58 | +121% | Bullish | |
| $0.3856 | $0.6819 | $1.27 | +72% | Bullish | |
| $0.2115 | $0.3896 | $0.7431 | -2% | Neutral | |
| $0.3551 | $0.6804 | $1.33 | +72% | Bullish | |
| $0.5313 | $1.06 | $2.12 | +167% | Bullish | |
| $0.6988 | $1.55 | $3.42 | +292% | Bullish | |
| $0.8168 | $1.82 | $4.17 | +358% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.2089 | $0.3965 | $0.5978 | +0.00% |
| August 2026 | $0.4037 | $0.4918 | $0.6258 | +24.04% |
| September 2026 | $0.4024 | $0.4967 | $0.6442 | +1.00% |
| October 2026 | $0.4724 | $0.5899 | $0.7777 | +18.76% |
| November 2026 | $0.5133 | $0.6474 | $0.8653 | +9.75% |
| December 2026 | $0.4747 | $0.6045 | $0.8183 | -6.63% |
Click any year to see its month-by-month TRIAS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
TriasLab's 2026 outlook centres on $0.3965, within a $0.2089 to $0.8183 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, TRIAS could reach as high as $0.8932, with a base case around $0.5977 and support toward $0.4325 — roughly +51% from $0.3965. Buyers look set to stay in control over this stretch.
Expect TRIAS to range from $0.2697 to $0.6303 through 2028. The $0.396 average target implies a 0% move from current prices. That is -34% versus the projected 2027 average. Price action looks broadly range-bound.
The TRIAS price prediction for 2029 points to an average of $0.3525 (low $0.2279, high $0.589) — a potential decline of -11% on today's $0.3965. A consolidation phase looks the most probable path here.
In 2030, TRIAS is projected to trade between $0.3632 and $1.02, averaging $0.5889 — a potential gain of +49% from today's $0.3965. That is up +67% on the projected 2029 average. Momentum favours further upside here.
TriasLab's 2031 outlook centres on $0.8773, within a $0.5176 to $1.58 range. That is up +49% on the projected 2030 average. That marks a +121% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, TRIAS could reach as high as $1.27, with a base case around $0.6819 and support toward $0.3856 — roughly +72% from $0.3965. Momentum favours further upside here.
Expect TRIAS to range from $0.2115 to $0.7431 through 2033. The $0.3896 average target implies a -2% move from current prices. That is -43% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The TRIAS price prediction for 2034 points to an average of $0.6804 (low $0.3551, high $1.33) — a potential gain of +72% on today's $0.3965. Momentum favours further upside here.
In 2035, TRIAS is projected to trade between $0.5313 and $2.12, averaging $1.06 — a potential gain of +167% from today's $0.3965. That is up +56% on the projected 2034 average. Buyers look set to stay in control over this stretch.
TriasLab's 2040 outlook centres on $1.55, within a $0.6988 to $3.42 range. That is up +47% on the projected 2035 average. That marks a +292% change versus current levels. Momentum favours further upside here.
By 2050, TRIAS could reach as high as $4.17, with a base case around $1.82 and support toward $0.8168 — roughly +358% from $0.3965. Buyers look set to stay in control over this stretch.
Investing $1,000 in TRIAS today (≈ 2,522.049014 TRIAS) could be worth
$4,577.72
+$3,577.72 (+358%) by 2050 · US Dollar
Based on the average projected TRIAS price of $1.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TRIASwould be worth at today's price.
$1,000 invested in TRIAS on Jul 1, 2025 (≈ 1,244.730062 TRIAS) would be worth
$493.54
-$506.46 (-50.6%) today · 0.49× · US Dollar
Based on a TRIAS entry price of $0.803387 vs. today's $0.396503.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.467118 | $848.83 | -15.1% |
| 1 month ago | $0.339345 | $1,168.44 | +16.8% |
| 3 months ago | $0.53143 | $746.11 | -25.4% |
| 6 months ago | $0.604301 | $656.14 | -34.4% |
| 1 year ago | $0.803387 | $493.54 | -50.6% |
| All time (1.1y) ago | $1.18 | $336.59 | -66.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TRIAS forecast.
Our base-case forecast reaches $0.79 around 2031.
Implied market cap at $0.79: $7.9M
The multi-year forecast shows a path of upside across many years, with notable gains in several milestones. In 2027 the avg price is $0.5977, with a 50.7% ROI and bullish sentiment, followed by a 2030 avg of $0.5889 and 48.5% ROI (max $1.02). In 2031 the avg rises to $0.8773 with a 121.3% ROI, and 2032 to $0.6819 (72% ROI).
The 2033 forecast dips slightly to an avg of $0.3896 with a -1.8% ROI, while 2034 rebounds to $0.6804 and 71.6% ROI. By 2035 the avg reaches $1.06 with a 166.9% ROI, and the bullish trajectory continues to 2040 with an avg of $1.55 and a 291.7% ROI. The long horizon culminates in 2050 with an avg of $1.82 and a 357.8% ROI, with a max price forecast of $4.17.
There are some years with negative or flat performance (e.g., 2028 at -0.1% ROI and 2029 at -11.1%), reflecting uncertainty and volatility inherent in long-range predictions. These figures are estimates, not guarantees, and should be considered within the context of market volatility and risk.
Tap a question to reveal the answer.
In 2030 the forecast shows min $0.3632, avg $0.5889, max $1.02, with a 48.5% ROI and bullish sentiment.
The forecast includes bullish years such as 2027 (avg $0.5977; ROI 50.7%), 2030 (avg $0.5889; ROI 48.5%), 2031 (avg $0.8773; ROI 121.3%), 2034 (avg $0.6804; ROI 71.6%), 2035 (avg $1.06; ROI 166.9%), 2040 (avg $1.55; ROI 291.7%), and 2050 (avg $1.82; ROI 357.8%). It also shows years with flat or negative outlook (2028 ROI -0.1%, 2029 ROI -11.1%, 2033 ROI -1.8%). These are estimates, not guarantees, and entail risk.
The forecast shows higher-price milestones: 2040 max $3.42 and 2050 max $4.17, with 2030 max $1.02. This indicates potential for substantial upside at longer horizons, though not guaranteed.
Market cap $3.97M; rank 1707.
TriasLab Community Discussion
0Share your TriasLab price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.